Responsible for managing and directing the project management for the North America and Australia/New Zealand region. Products include various agriculture pesticide uses and the projects span early development through commercialization.

SBM Life Science purchased the Bayer Advanced Home & Garden business in October, 2016. My role continues to involve the development of consumer pesticides for the North America and European markets. The projects often involve the development of a registered product from idea generation through commercialization or could involve product licensing from other companies.Both the North Americas and European projects involve a combination of technical and regulatory experts, marketing and supply chain.

Responsible for the development and commercialization of Bayer Advanced consumer products. These product lines span herbicides, fungicides, insecticides for consumers living in North America and Europe. Responsibilities involve leading teams of 4-10 people to develop Home & Garden pesticide products following formulation development, biology testing, product registration and industrialization.

Program ManagementServed as the program management office (PMO) for the development and global implementation of integrated Seed and Crop Protection commercial offers.• Led the first ever implementation of a joint commercial and R&D program within Syngenta and served as a member of the leadership team.• To facilitate global activities relating to the Corn Water Optimization program, established a program office that served as a hub for benefits realization, project management, communications and information management. • To ensure timely delivery of products and business changes, led and consulted with over ten project teams to align technology assets and business changes to global and regional commercial offers.Results of this multiyear effort included the launch of multiple integrated solutions in North America and Europe totaling more than $10 million in sales with impressive annual sales growth.Portfolio ManagementActed as the Seed Technology portfolio manager during 2012-13 during a period of rapid growth for the new organization.• To meet internal and external customer needs, initiated and planned eleven new projects to address business needs in an emerging technology area.• To balance strategic objectives with operational constraints, conducted project resource alignment and balancing to portfolio priorities, conducted scenario analyses and milestone planning that spanned multiple crop and technology portfolios.Project ManagementResponsible for implementing project management best practices across a five thousand employee R&D organization with more than $1 billion annual spend.• Completed many R&D projects that included improvements to resource forecasting, new idea prioritization and collaboration management.• Organized and led project management workshops for over one hundred LATAM, APAC and NAFTA project leaders and team members that increased their understanding of Syngenta and PMI best practices.

Developed the product positioning and launch strategy for a portable colorimeter in the architectural paint market. Conducted market research to determine competitive product attributes and pricing information. Completed the value proposition and a series of product evaluations, COGS analyses, discounting schedules and profitability forecasts for the Datacolor Scout™ product.

Finance – Developed and ensured the accuracy of quarterly and annual budget projections, monthly close and variance reporting for the Engineering Services organization. Analysis of this >$130million annual budget involved TM1 and SAP analyses to analyze trends, correct issues and communicate results to cost center managers, senior management and finance colleagues.Global Marketing – Implemented process validation procedures for the Strategic Planning organization to ensure product portfolios were accurate and revenue forecasts were consistent with financial projections. Also implemented the Global Pricing & Market Access comparative pricing matrix to gather and compare worldwide competitor prices to those of BMS oncology products.Operations – Project leader for the SAP BW Publish initiative to define and validate the technical and business supply chain publish processes. Implemented solutions for stakeholders to identify data issues early in the rollup process before monthly supply chain reports were completed. Established process data requirements for North America Orencia biologics processing which required new procedures to account for temperature sensitive raw materials and finished goods.

Reduced inventory and international supply chain costs for service facilities with low inventory turnover. Cost savings of $350K were identified following a series of site evaluations, financial analyses and internal consulting.

Implemented resource tracking and project prioritization systems during unprecedented telecommunications industry growth and subsequent downturn. During 2002, these systems supported four new product launches and helped maintain traditional productivity levels despite a 60% resource and headcount reduction.

Managed optical waveguide product development project, Submarine LS+, from idea conception through product commercialization. Following multistage product development, manufacturing conversion and stakeholder reviews, product sales exceeded $30million during 2000 alone. Completed pricing strategy and competitive analysis that successfully allowed Submarine LS+ to outsell all competitive products despite a later product launch date. To retain a key customer and maintain a bundled product portfolio, development was completed within 6 months at less than half the development costs of comparable projects.Facilitated the 1999 product launch of Submarine LEAF® optical fiber which generated over $10million annual profit. Responsibilities included conducting experiments, improving product throughput and coordinating transfer activities with the manufacturing organization.

Debugged three types of equipment during a $250 million facility expansion that increased total manufacturing capacity by 40%. Coordination among development, production and installation organizations resulted in a successful transition from pilot to full scale manufacturing.

Synthesized peptides for use as antiviral medications to treat HIV and Hepatitis-C. Continuously attained targeted compounds by conducting experiments and utilizing expertise in laboratory procedures.